AccurKardia has gained the US Food and Drug Administration's (FDA) breakthrough device designation for its AI-powered ‘AK+ ...
AccurKardia announced that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia ...
AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device ...